News
|
| Selecting suitable chemotherapies for PD1/PDL1 blockade to optimize the tumor immune microenvironment |
|
https://doi.org/10.18632/oncotarget.26028
|
| 32552-32553 |
Editorial
|
| Balance deficits in longterm pediatric ALL survivors |
|
https://doi.org/10.18632/oncotarget.25967
|
| 32554-32555 |
Research Papers
|
| Tumor cell density regulates matrix metalloproteinases for enhanced migration |
|
https://doi.org/10.18632/oncotarget.25863
|
| 32556-32569 |
|
| Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated nonmelanoma solid tumors |
|
https://doi.org/10.18632/oncotarget.25948
|
| 32570-32579 |
|
| Chromatin remodeling protein HELLS is upregulated by inactivation of the RBE2F pathway and is nonessential for osteosarcoma tumorigenesis |
|
https://doi.org/10.18632/oncotarget.25953
|
| 32580-32592 |
|
| Alendronateinduced disruption of actin cytoskeleton and inhibition of migration/invasion are associated with cofilin downregulation in PC3 prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25961
|
| 32593-32608 |
|
| Hematopoietic lineage cellspecific protein 1 HS1 a hidden player in migration invasion and tumor formation is overexpressed in ovarian carcinoma cells |
|
https://doi.org/10.18632/oncotarget.25975
|
| 32609-32623 |
|
| Quantitative screening of serum protein biomarkers by reverse phase protein arrays |
|
https://doi.org/10.18632/oncotarget.25976
|
| 32624-32641 |
|
| Mutational analysis of uterine cervical cancer that survived multiple rounds of radiotherapy |
|
https://doi.org/10.18632/oncotarget.25982
|
| 32642-32652 |
|
| The frequency of promoter DNA hypermethylation is decreased in colorectal neoplasms of familial adenomatous polyposis |
|
https://doi.org/10.18632/oncotarget.25987
|
| 32653-32666 |
|
| Involvement of GLUT1mediated glucose transport and metabolism in gefitinib resistance of nonsmallcell lung cancer cells |
|
https://doi.org/10.18632/oncotarget.25994
|
| 32667-32679 |
|
| Absence of correlation between radiationinduced CD8 Tlymphocyte apoptosis and sequelae in patients with prostate cancer accidentally overexposed to radiation |
|
https://doi.org/10.18632/oncotarget.26001
|
| 32680-32689 |
|
| A highthroughput fluorescence polarization assay for discovering inhibitors targeting the DNAbinding domain of signal transducer and activator of transcription 3 STAT3 |
|
https://doi.org/10.18632/oncotarget.26013
|
| 32690-32701 |
|
| Dual targeting of HSP70 does not induce the heat shock response and synergistically reduces cell viability in muscle invasive bladder cancer |
|
https://doi.org/10.18632/oncotarget.26021
|
| 32702-32717 |
|
| A patientderived orthotopic xenograft model enabling human highgrade urothelial cell carcinoma of the bladder tumor implantation growth angiogenesis and metastasis |
|
https://doi.org/10.18632/oncotarget.26024
|
| 32718-32729 |
Corrections
|
| Correction: Mechanosensitive caveolin1 activationinduced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility invadopodia formation and metastasis in vivo |
|
https://doi.org/10.18632/oncotarget.26065
|
| 32730-32730 |
|
| Correction: SEL1L SNP rs12435998 a predictor of glioblastoma survival and response to radiochemotherapy |
|
https://doi.org/10.18632/oncotarget.26066
|
| 32731-32731 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
